JP2018524406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018524406A5 JP2018524406A5 JP2018521488A JP2018521488A JP2018524406A5 JP 2018524406 A5 JP2018524406 A5 JP 2018524406A5 JP 2018521488 A JP2018521488 A JP 2018521488A JP 2018521488 A JP2018521488 A JP 2018521488A JP 2018524406 A5 JP2018524406 A5 JP 2018524406A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkyl
- cycloalkyl
- formula
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 44
- 229910052739 hydrogen Inorganic materials 0.000 claims description 43
- 125000000217 alkyl group Chemical group 0.000 claims description 42
- 150000001875 compounds Chemical class 0.000 claims description 38
- 229910052799 carbon Inorganic materials 0.000 claims description 25
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 24
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 20
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 20
- 229910052760 oxygen Inorganic materials 0.000 claims description 18
- 229910052717 sulfur Inorganic materials 0.000 claims description 18
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 10
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 10
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 10
- 150000003852 triazoles Chemical class 0.000 claims description 10
- -1 C 1 -C 6 alkoxy Chemical group 0.000 claims description 9
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000012453 solvate Substances 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 4
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 229930192474 thiophene Natural products 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000002924 anti-infective effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 description 12
- 125000004423 acyloxy group Chemical group 0.000 description 3
- 238000000034 method Methods 0.000 description 2
- 0 Cc1cc(N(CC(C*)O2)C2=O)cc(C=*)c1N1CCCCCCC1 Chemical compound Cc1cc(N(CC(C*)O2)C2=O)cc(C=*)c1N1CCCCCCC1 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562193963P | 2015-07-17 | 2015-07-17 | |
| US62/193,963 | 2015-07-17 | ||
| PCT/US2016/042486 WO2017015106A1 (en) | 2015-07-17 | 2016-07-15 | Substituted phenyloxazolidinones for antimicrobial therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020086709A Division JP7232212B2 (ja) | 2015-07-17 | 2020-05-18 | 抗微生物治療のための置換フェニルオキサゾリジノン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018524406A JP2018524406A (ja) | 2018-08-30 |
| JP2018524406A5 true JP2018524406A5 (enExample) | 2019-06-13 |
| JP6786598B2 JP6786598B2 (ja) | 2020-11-18 |
Family
ID=57834866
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018521488A Active JP6786598B2 (ja) | 2015-07-17 | 2016-07-15 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2020086709A Active JP7232212B2 (ja) | 2015-07-17 | 2020-05-18 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2021143166A Withdrawn JP2021183647A (ja) | 2015-07-17 | 2021-09-02 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2023127905A Active JP7585405B2 (ja) | 2015-07-17 | 2023-08-04 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2024140841A Pending JP2024152930A (ja) | 2015-07-17 | 2024-08-22 | 抗微生物治療のための置換フェニルオキサゾリジノン |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020086709A Active JP7232212B2 (ja) | 2015-07-17 | 2020-05-18 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2021143166A Withdrawn JP2021183647A (ja) | 2015-07-17 | 2021-09-02 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2023127905A Active JP7585405B2 (ja) | 2015-07-17 | 2023-08-04 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2024140841A Pending JP2024152930A (ja) | 2015-07-17 | 2024-08-22 | 抗微生物治療のための置換フェニルオキサゾリジノン |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10550092B2 (enExample) |
| EP (2) | EP3932917A3 (enExample) |
| JP (5) | JP6786598B2 (enExample) |
| KR (1) | KR102511898B1 (enExample) |
| CN (2) | CN113603683B (enExample) |
| AU (3) | AU2016295165B2 (enExample) |
| BR (1) | BR112018000991A2 (enExample) |
| CA (1) | CA2990260A1 (enExample) |
| EA (2) | EA202190167A1 (enExample) |
| ES (1) | ES2897973T3 (enExample) |
| WO (1) | WO2017015106A1 (enExample) |
| ZA (1) | ZA201800189B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113603683B (zh) * | 2015-07-17 | 2024-06-14 | 结核病药物开发全球联盟公司 | 用于抗微生物治疗的经取代苯基噁唑烷酮 |
| WO2017066964A1 (en) * | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
| CN108727406B (zh) * | 2017-03-28 | 2021-12-07 | 北京协和制药二厂 | 含氮杂环取代的苯并噁嗪噁唑烷酮类化合物及其制备方法和用途 |
| KR102777328B1 (ko) | 2018-07-25 | 2025-03-10 | 자이두스 라이프사이언시즈 리미티드 | 포유류 감염 치료를 위한 신규 화합물 |
| WO2020147504A1 (en) * | 2019-01-18 | 2020-07-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
| WO2020234636A1 (en) | 2019-05-17 | 2020-11-26 | Cadila Healthcare Limited | Novel compounds for the treatment of mammalian infections |
| CN110922411B (zh) * | 2019-11-27 | 2021-06-04 | 合肥远志医药科技开发有限公司 | 一种药物中间体的合成方法 |
| WO2021184339A1 (en) * | 2020-03-20 | 2021-09-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
| CN113999152B (zh) * | 2021-07-14 | 2023-05-09 | 上海凌富药物研究有限公司 | 一种顺式-1-苄基-2,4-二烷氧基羰基氮杂环丁烷的合成方法 |
| WO2024035618A1 (en) * | 2022-08-10 | 2024-02-15 | Merck Sharp & Dohme Llc | Processes for preparing oxazolidinone compounds |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115155A (en) * | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| US5952324A (en) * | 1994-11-15 | 1999-09-14 | Pharmacia & Upjohn Company | Bicyclic oxazine and thiazine oxazolidinone antibacterials |
| CA2218088A1 (en) * | 1995-05-11 | 1996-11-14 | Pharmacia & Upjohn Company | Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
| US6255304B1 (en) * | 1997-05-30 | 2001-07-03 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| HK1040707A1 (zh) * | 1998-11-27 | 2002-06-21 | 法玛西雅厄普约翰美国公司 | 具有硫代羰基官能團的噁唑烷酮抗菌劑 |
| EP1451164A2 (en) * | 2001-07-12 | 2004-09-01 | PHARMACIA & UPJOHN COMPANY | Amide derivatives having improved solubility |
| AU2003207340A1 (en) * | 2002-02-28 | 2003-09-09 | Astrazeneca Ab | 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents |
| AU2003224345A1 (en) * | 2002-04-30 | 2003-11-17 | Orchid Chemicals & Pharmaceuticals | Antibacterial agents |
| TW200403240A (en) | 2002-06-28 | 2004-03-01 | Upjohn Co | Difluorothioacetamides of oxazolidinones as antibacterial agents |
| US6875784B2 (en) * | 2002-10-09 | 2005-04-05 | Pharmacia & Upjohn Company | Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives |
| CN1237056C (zh) * | 2002-12-25 | 2006-01-18 | 中国科学院上海药物研究所 | 噁唑烷酮类化合物、其制备方法和用途 |
| CA2536480A1 (en) * | 2003-08-25 | 2005-03-03 | Warner-Lambert Company Llc | Novel antimicrobial aryloxazolidinone compounds |
| EP1819702A1 (en) * | 2004-11-29 | 2007-08-22 | Pharmacia & Upjohn Company LLC | Thiazepine oxazolidinones as antibacterial agents |
| US7332611B2 (en) * | 2005-05-06 | 2008-02-19 | University Of South Florida | N-thiolated 2 oxazolidone antibiotics |
| JP2008544979A (ja) * | 2005-06-29 | 2008-12-11 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗菌剤としてのホモモルホリンオキサゾリジノン |
| JP2009500389A (ja) * | 2005-07-06 | 2009-01-08 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗菌剤としてのアゼチジンおよびシクロブタンを含むオキサゾリジノンカルボキサミド |
| JP5613656B2 (ja) * | 2008-03-26 | 2014-10-29 | グローバル、アライアンス、フォア、ティービー、ドラッグ、ディベロップメント | 置換されたフェニルオキサゾリジノンと共有結合した二環式ニトロイミダゾール |
| KR100980681B1 (ko) * | 2008-09-16 | 2010-09-07 | 한국과학기술연구원 | 디플루오로페닐 유도체를 갖는 신규한 옥사졸리디논 유도체또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 하는 항생제 조성물 |
| US20110053916A1 (en) | 2009-08-14 | 2011-03-03 | Vertex Pharmaceuticals Incorporated | Pyrimidine compounds as tuberculosis inhibitors |
| CN113603683B (zh) | 2015-07-17 | 2024-06-14 | 结核病药物开发全球联盟公司 | 用于抗微生物治疗的经取代苯基噁唑烷酮 |
| JP2023127905A (ja) * | 2022-03-02 | 2023-09-14 | パナソニックＩｐマネジメント株式会社 | 物品管理システム、物品管理方法及びプログラム |
-
2016
- 2016-07-15 CN CN202111073361.5A patent/CN113603683B/zh active Active
- 2016-07-15 AU AU2016295165A patent/AU2016295165B2/en active Active
- 2016-07-15 EP EP21185896.4A patent/EP3932917A3/en active Pending
- 2016-07-15 US US15/738,503 patent/US10550092B2/en active Active
- 2016-07-15 EP EP16828300.0A patent/EP3307268B1/en active Active
- 2016-07-15 WO PCT/US2016/042486 patent/WO2017015106A1/en not_active Ceased
- 2016-07-15 CN CN201680054227.1A patent/CN108348507B/zh active Active
- 2016-07-15 CA CA2990260A patent/CA2990260A1/en active Pending
- 2016-07-15 BR BR112018000991A patent/BR112018000991A2/pt not_active Application Discontinuation
- 2016-07-15 ES ES16828300T patent/ES2897973T3/es active Active
- 2016-07-15 EA EA202190167A patent/EA202190167A1/ru unknown
- 2016-07-15 EA EA201792566A patent/EA037643B1/ru unknown
- 2016-07-15 JP JP2018521488A patent/JP6786598B2/ja active Active
- 2016-07-15 KR KR1020187003093A patent/KR102511898B1/ko active Active
-
2018
- 2018-01-10 ZA ZA2018/00189A patent/ZA201800189B/en unknown
-
2020
- 2020-01-13 US US16/740,660 patent/US11964949B2/en active Active
- 2020-05-18 JP JP2020086709A patent/JP7232212B2/ja active Active
-
2021
- 2021-07-16 AU AU2021205116A patent/AU2021205116B2/en active Active
- 2021-09-02 JP JP2021143166A patent/JP2021183647A/ja not_active Withdrawn
-
2022
- 2022-11-11 AU AU2022268387A patent/AU2022268387A1/en not_active Abandoned
-
2023
- 2023-08-04 JP JP2023127905A patent/JP7585405B2/ja active Active
-
2024
- 2024-08-22 JP JP2024140841A patent/JP2024152930A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018524406A5 (enExample) | ||
| JP2020122016A5 (enExample) | ||
| JP2019513778A5 (enExample) | ||
| JP2016503799A5 (enExample) | ||
| PE20191541A1 (es) | Composiciones y metodos para inhibir la accion de la arginasa | |
| JP2016506960A5 (enExample) | ||
| JP2010524932A5 (enExample) | ||
| IL96821A (en) | 3-aminopiperidine derivatives, related nitrogen containing heterocycles and pharmaceutical compositions containing them | |
| MX385731B (es) | Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
| JP2013537203A5 (enExample) | ||
| JP2014521688A5 (enExample) | ||
| AR067896A1 (es) | Procedimiento para sintetizar compuestos utiles para tratar hepatitis c | |
| JP2019501125A5 (enExample) | ||
| JP2016121196A5 (enExample) | ||
| JP2009532486A5 (enExample) | ||
| JP2020519687A5 (enExample) | ||
| JP2016506961A5 (enExample) | ||
| JP2013531029A5 (enExample) | ||
| JP2010527913A5 (enExample) | ||
| JP2018527301A5 (ja) | アジリジン含有ｄｎａアルキル化剤 | |
| JP2019514955A5 (enExample) | ||
| CN111601797A (zh) | 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用 | |
| AR121299A1 (es) | Inhibidores heterocíclicos de pad4 | |
| RU2017133660A (ru) | Новые гетероциклические соединения и их применение в профилактике или лечении бактериальных инфекций | |
| MX2024002409A (es) | Terapias contra el cancer. |